Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Atezolizumab [USAN:INN]
RN: 1380723-44-3
UNII: 52CMI0WC3Y

Note

  • A monoclonal antibody that targets programmed death-ligand 1 (CD274 ANTIGEN) and is used to treat urothelial carcinoma, the most common type of bladder cancer.

Molecular Formula

  • C6446-H9902-N1706-O1998-S42
 

Classification Codes

  • Antineoplastic Agents
  • Treatment of Solid Tumors

Names and Synonyms

Name of Substance

  • Atezolizumab
  • Atezolizumab [USAN:INN]

Synonyms

  • anti-PD-L1 monoclonal antibody MPDL3280A
  • Atezolizumab
  • Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer
  • MPDL 3280A
  • MPDL-3280A
  • MPDL3280A
  • RG 7446
  • Tecentriq
  • UNII-52CMI0WC3Y

Registry Numbers

CAS Registry Number

  • 1380723-44-3

FDA UNII

  • 52CMI0WC3Y

Other Registry Number

  • 1422185-06-5

System Generated Number

  • 1380723443